Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 135 (RPL21P135)

Target: RPL21P135
Molecular classification: Other, Specifically, processed pseudogene

Overview

Ribosomal protein L21 pseudogene 135 (RPL21P135) is a processed pseudogene, meaning it is a non-functional genomic DNA sequence similar to the functional ribosomal protein L21 gene but does not produce a protein product. As a pseudogene, RPL21P135 has no known biological function, involvement in disease, or therapeutic relevance. It is one of many dispersed pseudogenes derived from the ribosomal protein L21 gene and serves as a genomic relic without coding capacity or known regulatory function.

Other names: Ribosomal protein L21 pseudogene 135RPL21P135

Mechanism of action

None (no mechanism since the pseudogene does not produce a functional product)

Biological functions

None (as a pseudogene, RPL21P135 does not encode a functional protein and has no known biological function)

Disease associations

None documented (not associated with any disease mechanism or phenotype)

Safety considerations

None (no known relevance to safety or therapeutic challenges—pseudogene status means no functional role or therapeutic liability)

Interacting drugs

None (no drugs interact with a pseudogene; there are no molecular interactions or pharmacological targeting for RPL21P135)

Biomarkers

None (not used as a biomarker for patient selection, prognosis, or efficacy monitoring)

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 135 (RPL21P135).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 135 (RPL21P135).

Explore the full profile